Crossover or conversion between the homologous regions of glycophorin A (GYPA) and glycophorin B (GYPB) gives rise to several different hybrid glycophorin genes encoding a number of different glycophorin variant phenotypes which bear low prevalence antigens in the MNS blood group system. GP.Mur is the main glycophorin variant phenotype which causes hemolytic transfusion reaction (HTR) and hemolytic disease of the fetus and newborn (HDFN) in East and Southeast Asians. The detection of glycophorin variant phenotypes using serological methods is limited to phenotyping reagents that are not commercially available. Moreover, the red blood cells used for antibody identification are usually of the GP.Mur phenotype. The current Polymerase Chain Reaction (PCR)-based methods and loop-mediated isothermal amplification (LAMP) are available alternatives to phenotyping that allow for the specific detection of glycophorin variant phenotypes. This review highlights the molecular detection method for glycophorins A and B variant phenotypes and their clinical relevance.
Molecular Detection of Glycophorins A and B Variant Phenotypes and their Clinical Relevance.
Siti Nazihahasma Hassan,Kannan Thirumulu Ponnuraj,Suharni Mohamad,R. Hassan,W. S. Wan Ab Rahman
Published 2019 in Transfusion Medicine Reviews
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Transfusion Medicine Reviews
- Publication date
2019-02-23
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-76 of 76 references · Page 1 of 1
CITED BY
Showing 1-10 of 10 citing papers · Page 1 of 1